A Phase IV Study to Assess the Safety of EupentaTM Inj

Clinical trial NCT04056728 · UNKNOWN

Trial details

NCT number: NCT04056728
Sponsor: LG Chem
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Hepatitis B Diphtheria Haemophilus Influenzae Type B Infection Tetanus Pertussis

Start date: 2019-09-23
Primary completion: 2020-10-12
Enrollment: 3000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.